These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8786002)

  • 41. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins.
    Terao A; Oikawa M; Saito M
    Brain Res; 1993 Sep; 622(1-2):257-61. PubMed ID: 8242363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat.
    Lenz HJ; Burlage M; Raedler A; Greten H
    Gastroenterology; 1988 Mar; 94(3):598-602. PubMed ID: 3257450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats.
    Shimizu N; Hori T; Nakane H
    Brain Behav Immun; 1994 Mar; 8(1):14-23. PubMed ID: 8003768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central action of interleukin 1 beta on intestinal motility in rats: mediation by two mechanisms.
    Fargeas MJ; Fioramonti J; Bueno L
    Gastroenterology; 1993 Feb; 104(2):377-83. PubMed ID: 8425679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central action of recombinant interleukin-1 to inhibit acid secretion in rats.
    Saperas ES; Yang H; Rivier C; Taché Y
    Gastroenterology; 1990 Dec; 99(6):1599-606. PubMed ID: 2121579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
    Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
    J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat.
    Rothwell NJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E111-5. PubMed ID: 2783532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticotropin-releasing factor inhibits gastric emptying in dogs: studies on its mechanism of action.
    Pappas TN; Welton M; Debas HT; Rivier J; Taché Y
    Peptides; 1987; 8(6):1011-4. PubMed ID: 3502024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fourth ventricle injection of corticotropin-releasing factor and gastric emptying of glucose during gastric fill.
    Smedh U; Uvnäs-Moberg K; Grill HJ; Kaplan JM
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G1000-3. PubMed ID: 8572209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1.
    Morimoto A; Murakami N; Nakamori T; Sakata Y; Watanabe T
    J Physiol; 1989 Apr; 411():245-56. PubMed ID: 2559195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of prostaglandins in interleukin-1 induced gastroparesis.
    McCarthy DO; Daun JM
    Physiol Behav; 1992 Aug; 52(2):351-3. PubMed ID: 1523264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
    Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
    Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
    Riviere PJ; Pascaud X; Chevalier E; Junien JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-1 alpha and interleukin-1 beta stimulate adrenocorticotropin secretion in the rat through a similar hypothalamic receptor(s): effects of interleukin-1 receptor antagonist protein.
    Matta SG; Linner KM; Sharp BM
    Neuroendocrinology; 1993 Jan; 57(1):14-22. PubMed ID: 8386818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone.
    Borsody MK; Weiss JM
    Neuroimmunomodulation; 2002-2003; 10(2):101-21. PubMed ID: 12372984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-1 receptor antagonist does not prevent endotoxin-induced inhibition of gastric acid secretion in rats.
    Saperas E; Taché Y
    Dig Dis Sci; 1994 Jan; 39(1):152-6. PubMed ID: 8281850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peripheral adrenomedullin inhibits gastric emptying through CGRP8-37 -sensitive receptors and prostaglandins pathways in rats.
    Martinez V; Wang L; Taché Y
    Peptides; 2006 Jun; 27(6):1376-82. PubMed ID: 16337713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta.
    Sandi C; Guaza C
    Eur J Pharmacol; 1995 Feb; 274(1-3):17-23. PubMed ID: 7768270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention by interleukin-1 of intracisternally injected thyrotropin-releasing hormone (TRH)-induced gastric mucosal lesions in rats.
    Okumura T; Uehara A; Kitamori S; Okamura K; Takasugi Y; Namiki M
    Neurosci Lett; 1991 Apr; 125(1):31-3. PubMed ID: 1907003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
    Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
    J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.